Chapter 23: Disorders of the Hematologic System Flashcards
Hypercoagulability
exagerrated hemostasis
thrombocytosis (>1,000,000)
predispose to thrombosis
Arterial Thrombi
associated with turbulent blood flow = atherosclerotic plaque, hyperlipidemia, smoking, DM
treat with antiplatelet aggregates (ASA)
Venous Thrombi
associated with stasis of blood flow = immobility, sickle cell, elevated estrogen, malignancy, obesity
treat with anticoagulants
Primary (Essential) Thrombocytosis
disorder of stem cells
results in dysfunctional platelets
Secondary (Reactive) Thrombocytosis
condition that stimulates thrombopoietin
tissue damage, cancer, chronic inflammatory disorders
Antiphospholipid Syndrome
autoantibodies (IgG) against anticoagulant phospholipids = inc coag activity
recurrent venous and arterial thrombosis
recurrent fetal loss
thrombocytopenia
Thrombocytopenia
platelet count <150,000
commonly causes leukemia, splenomegaly (sequestration), and autoimmune responses
_____ bleeding seen in platelet disorders
Superficial
petechia, purpua, ecchymosis, gingival bleeding, epistaxis
Drug-Induced Thrombocytopenia
antigen-anitbody response that results in plt destruction
Treat by D/C drug and plt count increases
Heparin-Induced Thrombocytopenia (HIT)
person develops antibodies to plt Factor 4 = activates platelets = thrombosis
can occur with increased levels of serotonin
Stop heparin and give direct thrombin inhibitor
Immune Thrombocytopenia Purpura (ITP)
autoimmune cell d/o = T-cell dysfunction
plt antibody formation and excess destruction of plts
platelets do not aggregate = bleeding
Clinical Manifestations of ITP
ecchymosis bleeding from gums epistaxis melena splenomegaly (spleen is site for plt destruction)
Treatment for ITP
if no symptoms = no treatment
can give steroids (suppress immune response)
infuse plts
IV gamma globulin (slows rate of plt destruction, temp fix)
Thrombotic Thrombocytopenia Purpura (TTP)
Deficiency of enzyme Adam T513 that degrades vWF
more thrombosis than bleeding
EMERGENCY = wide spread occlusions
thrombocytopenia + hemolytic anemia + neuro abnormalities
Clinical Manifestations of TTP
purpura petechia vaginal bleeding neuro symptoms - altered LOC, seizures jaundice (inc bilirubin)
Treatment for TTP (emergent)
Plasmapheresis
FFP
Give missing enzyme
von Willbrand Disease
deficiency or defect in von Willebrand Factor (vWF)
affects both primary and secondary hemostasis
lacking plt function, not plts
DDAVP (synthetic vasopressin)
treatment for von Willebrand Disease
stimulates endothelial cells to release vWF
Hemophilia A
Deficiency or defect of Factor VIII
affects BOTH intrinsic and extrinsic pathways
see increase in both PTT and PT
Clinical Manifestations of Hemophilia A
deep, systemic bleeding
soft tissues, GI tract, joints
joint bleeding can be seen in children when they start walking
Hemophilia B
Deficiency of Factor IX
involved in intrinsic pathway = PTT will be elevated
Factors II, VII, IX, X, prothrombin, and protein C require ______ to convert to their active form
Vitamin K
Disseminated Intravascular Coagulopathy (DIC)
widespread coagulation and bleeding = thrombo-hemorrhagic disorder
Intrinsic Causes of DIC
activation d/t severe endothelial damage
viruses/bacteria, hypoxia, acidosis, shock, hypo/hyperthermia
Extrinsic Causes of DIC
release of extensive tissue factor
OB complications, trauma, burns, sepsis, cancers
Erythroblastosis Fetalis
hemolytic disease that occurs in Rh positive newborns of Rh negative mothers
Hydrops Fetalis
mother’s immune system causes baby’s RBCs to break down = anemia
see splenomegaly and hepatomegaly
Kernicterus
abnormally high levels of unconjugated bilirubin (toxic)
results in severe brain damage or death
Hemodilution
caused by movement of fluid into the intravascular space in hypovolemic conditions